You May Also Be Interested In:
Molecular Formula C19H20ClNO
Packing 25KG/FIBRE DRUM
Delivery stock is available
Bezafibrate improves markers of combined hyperlipidemia, effectively reducing LDL and triglycerides and improving HDL levels, The main effect on cardiovascular morbidity is in patients with the metabolic syndrome, the features of which are attenuated by bezafibrate. Studies show that in patients with impaired glucose tolerance, bezafibrate may delay progress to diabetes, and in those with insulin resistance it slowed progress in the HOMA severity marker. 
Products covered by valid patents are not offered or supplied for commercial use. The patents position should be verified by the customer.